Approval · Notice of Compliance 32928 · 2024
CYSVIEW: Notice of Compliance 32928
Issued March 21, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32928
- Date
- March 21, 2024
- Company
- Photocure AsaOslo, Oslo, Norway
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Modification of the indication and conversion of the Product Monograph to the master template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYSVIEW | Not yet assigned | — |
Medicinal ingredients
- HEXAMINOLEVULINATE HYDROCHLORIDE 100 MG per VIAL